Search Results - "Pieri, Giulia"

Reduced exposure to calcineurin inhibitors early after liver transplantation prevents recurrence of hepatocellular carcinoma by Rodríguez-Perálvarez, Manuel, Tsochatzis, Emmanuel, Naveas, María Carmen, Pieri, Giulia, García-Caparrós, Carmen, O’Beirne, James, Poyato-González, Antonio, Ferrín-Sánchez, Gustavo, Montero-Álvarez, Jose Luis, Patch, David, Thorburn, Douglas, Briceño, Javier, De la Mata, Manuel, Burroughs, Andrew Kenneth

“…Background & Aims Recurrence of hepatocellular carcinoma (HCC) is a major complication after liver transplantation (LT). The initial immunosuppression protocol…”
Get full text

Burden of multimorbidity in relation to age, gender and immigrant status: a cross-sectional study based on administrative data by Lenzi, Jacopo, Avaldi, Vera Maria, Rucci, Paola, Pieri, Giulia, Fantini, Maria Pia

“…ObjectivesMany studies have investigated multimorbidity, whose prevalence varies according to settings and data sources. However, few studies on this topic…”
Get full text

Safety and Efficacy of Atezolizumab/Bevacizumab in Patients with Hepatocellular Carcinoma and Impaired Liver Function: A Systematic Review and Meta-Analysis by Pasta, Andrea, Calabrese, Francesco, Jaffe, Ariel, Labanca, Sara, Marenco, Simona, Pieri, Giulia, Plaz Torres, Maria Corina, Strazzabosco, Mario, Giannini, Edoardo G.

“…Abstract Background: Safety and outcome of atezolizumab/bevacizumab in Child-Pugh B patients with hepatocellular carcinoma (HCC) have not been completely…”
Get full text

The Contribution of Case Mix, Skill Mix and Care Processes to the Outcomes of Community Hospitals: A Population-Based Observational Study by Pianori, Davide, Adja, Kadjo Yves Cedric, Lenzi, Jacopo, Pieri, Giulia, Rossi, Andrea, Reno, Chiara, Fantini, Maria Pia

“…Community hospitals (CHs) could address the emerging complex care needs of patients. We investigated which characteristics of patients' and CHs affect patient…”
Get full text

Prevention of hepatitis C recurrence by bridging sofosbuvir/ribavirin from pre‐ to post‐liver transplant: a real‐life strategy by Donato, Maria Francesca, Morelli, Cristina, Romagnoli, Renato, Invernizzi, Federica, Mazzarelli, Chiara, Iemmolo, Rosa Maria, Montalbano, Marzia, Lenci, Ilaria, Bhoori, Sherrie, Pieri, Giulia, Berardi, Sonia, Caraceni, Paolo, Martini, Silvia, Angeli, Paolo, Belli, Luca Saverio, Bernabucci, Veronica, Malinverno, Federica, Monico, Sara, Ottobrelli, Antonio, Romano, Antonietta, Strona, Silvia, Tamè, Maria Rosa, Visco‐Comandini, Ubaldo, Cavenago, Margherita, De Carlis, Luciano, Di Benedetto, Fabrizio, Dondossola, Daniele, Ettorre, Giuseppe Maria, Mazzaferro, Vincenzo, Montin, Umberto, Pinna, Antonio Daniele, Rossi, Giorgio, Salizzoni, Mauro, Tisone, Giuseppe

“…Background & Aims Hepatitis C virus (HCV) re‐infection following liver transplant (LT) is associated with reduced graft and patient survival. Before…”
Get full text

Peripheral blood cytopaenia limiting initiation of treatment in chronic hepatitis C patients otherwise eligible for antiviral therapy by Giannini, Edoardo G., Marenco, Simona, Fazio, Valentina, Pieri, Giulia, Savarino, Vincenzo, Picciotto, Antonino

“…Background In patients with chronic hepatitis C virus (HCV) infection, the presence of peripheral blood cytopaenia may represent an obstacle to pegylated…”
Get full text

Liver in haematological disorders by Pieri, Giulia, MD, Theocharidou, Eleni, MD, Burroughs, Andrew K., FRCP, FMedSci

“…Abstract Prothrombotic haematological disorders, in particular myeloproliferative disorders, are identified in a significant proportion of patients with…”
Get full text

Obeticholic Acid Improves Aminotransferases Early during Treatment in Patients with Primary Biliary Cholangitis Not Responding to Ursodeoxycholic Acid: A Study in Clinical Practice by Labanca, Sara, Cacciato, Valentina, Borro, Paolo, Marenco, Simona, Pieri, Giulia, Picciotto, Antonino, Plaz Torres, Maria, Giannini, Edoardo

“…Obeticholic acid (OCA) improves cholestasis and is generally well tolerated in patients with primary biliary cholangitis (PBC) not responding, or intolerant,…”
Get full text

Integrated phenotyping of the anti-cancer immune response in HIV-associated hepatocellular carcinoma by Pinato, David J., Kaneko, Takahiro, D’Alessio, Antonio, Forner, Alejandro, Fessas, Petros, Minguez, Beatriz, Giannini, Edoardo G., Grillo, Federica, Díaz, Alba, Mauri, Francesco A., Fulgenzi, Claudia A.M., Dalla Pria, Alessia, Goldin, Robert D., Pieri, Giulia, Toniutto, Pierluigi, Avellini, Claudio, Plaz Torres, Maria Corina, Akarca, Ayse U., Marafioti, Teresa, Bhoori, Sherrie, Miró, Jose María, Bower, Mark, Bräu, Norbert, Mazzaferro, Vincenzo

“…HIV-seropositivity shortens survival in patients with hepatocellular carcinoma (HCC). Although risk factors for HCC including HCV infection can influence T…”
Get full text

Risk adjustment for cesarean delivery rates: how many variables do we need? An observational study using administrative databases by Stivanello, Elisa, Rucci, Paola, Carretta, Elisa, Pieri, Giulia, Fantini, Maria P

“…Various studies indicate that inter-hospital comparisons have to take case mix into account and that risk adjustment procedures are necessary to control for…”
Get full text

Risk adjustment for inter-hospital comparison of caesarean delivery rates in low-risk deliveries by Stivanello, Elisa, Rucci, Paola, Carretta, Elisa, Pieri, Giulia, Seghieri, Chiara, Nuti, Sabina, Declercq, Eugene, Taglioni, Martina, Fantini, Maria Pia

“…Caesarean delivery (CD) rates have been frequently used as quality measures for maternity service comparisons. More recently, primary CD rates (CD in women…”
Get full text

Risk adjustment models for interhospital comparison of CS rates using Robson's ten group classification system and other socio-demographic and clinical variables by Colais, Paola, Fantini, Maria P, Fusco, Danilo, Carretta, Elisa, Stivanello, Elisa, Lenzi, Jacopo, Pieri, Giulia, Perucci, Carlo A

“…Caesarean section (CS) rate is a quality of health care indicator frequently used at national and international level. The aim of this study was to assess…”
Get full text

Towards an integrated management model for hepatocellular carcinoma by Giannini, Edoardo G., Pieri, Giulia, Plaz Torres, Maria Corina

Get full text

Hepatocellular carcinoma in patients with autoimmune hepatitis by Pasta, Andrea, Pieri, Giulia, Plaz Torres, Maria Corina, Trevisani, Franco, Giannini, Edoardo G.

Get full text

Letter to the Editor: Is CAD-LT score as a predictor of coronary artery disease following liver transplantation? by Labanca, Sara, Pasta, Andrea, Cariati, Sara, Calabrese, Francesco, Pieri, Giulia, Plaz Torres, Maria Corina, Marenco, Simona, Giannini, Edoardo G.

Get full text

Levels of Alkaline Phosphatase and Bilirubin Are Surrogate End Points of Outcomes of Patients With Primary Biliary Cirrhosis: An International Follow-up Study by Lammers, Willem J, van Buuren, Henk R, Hirschfield, Gideon M, Janssen, Harry L.A, Invernizzi, Pietro, Mason, Andrew L, Ponsioen, Cyriel Y, Floreani, Annarosa, Corpechot, Christophe, Mayo, Marlyn J, Battezzati, Pier M, Parés, Albert, Nevens, Frederik, Burroughs, Andrew K, Kowdley, Kris V, Trivedi, Palak J, Kumagi, Teru, Cheung, Angela, Lleo, Ana, Imam, Mohamad H, Boonstra, Kirsten, Cazzagon, Nora, Franceschet, Irene, Poupon, Raoul, Caballeria, Llorenç, Pieri, Giulia, Kanwar, Pushpjeet S, Lindor, Keith D, Hansen, Bettina E

“…Background & Aims Noninvasive surrogate end points of long-term outcomes of patients with primary biliary cirrhosis (PBC) are needed to monitor disease…”
Get full text

C-reactive protein and bacterial infection in cirrhosis by Pieri, Giulia, Agarwal, Banwari, Burroughs, Andrew K

“…In the general population, C-reactive protein (CRP) level increases in the presence of acute or chronic inflammation and infections. In patients with…”
Get full text

Spinal Muscular Atrophy, types I and II: What are the differences in body composition and resting energy expenditure? by Bertoli, Simona, De Amicis, Ramona, Mastella, Chiara, Pieri, Giulia, Giaquinto, Ester, Battezzati, Alberto, Leone, Alessandro, Baranello, Giovanni

“…Summary Background & aims Different neuromuscular functional domains in types I and II Spinal Muscular Atrophy (SMAI and SMAII) could lead to differences in…”
Get full text

The Royal Free Hospital score: a calibrated prognostic model for patients with cirrhosis admitted to intensive care unit. Comparison with current models and CLIF-SOFA score by Theocharidou, Eleni, Pieri, Giulia, Mohammad, Ali Omar, Cheung, Michelle, Cholongitas, Evangelos, Agarwal, Banwari, Banwari, Agarwal, Burroughs, Andrew K

“…Prognosis for patients with cirrhosis admitted to intensive care unit (ICU) is poor. ICU prognostic models are more accurate than liver-specific models. We…”
Get full text

Safety and efficacy of venous thromboembolism prophylaxis in patients with cirrhosis: A systematic review and meta‐analysis by Pasta, Andrea, Calabrese, Francesco, Labanca, Sara, Marenco, Simona, Pieri, Giulia, Plaz Torres, Maria Corina, Intagliata, Nicolas M., Caldwell, Stephen H., Giannini, Edoardo G.

“…Background & Aims Patients with cirrhosis are considered in a haemostatic balance, though weaker than in normal subjects. In these patients, however, the use…”
Get full text